Photo used for illustrative purpose.
The Ministry of Health and Prevention (MoHAP) on Thursday announced it has approved the Russian COVID-19 vaccine, Sputnik V, for emergency use, making it the third such vaccine to be approved for use in the UAE.
The decision comes as part of the UAE's comprehensive and integrated efforts to ensure increased prevention levels against the virus and to safeguard the health of the country's citizens and residents.
The UAE has hosted the third phase of clinical trials of the vaccine, which was developed by the Gamaleya Research Institute of Epidemiology and Microbiology and the Ministry of Health of the Russian Federation.
Study results have demonstrated the effectiveness of the vaccine in triggering a strong antibody response against the virus, its safety for use, and its compliance with international safety and effectiveness standards.
Great efforts reflect the vision of delivering services and providing the vaccine to the citizens, says Hessa Tahlak.
The initiative aims to ensure the senior citizens who are unable to visit medical centres have easy access to the vaccine.
MoHAP has started administering the vaccine to medical and nursing staff at Al Qassimi Hospital for Women and Children.
This came during his meeting, on Tuesday, with Dr Susan Mumm, the new Chancellor of the American University Sharjah, in the presence of a number of members of the university's board of trustees and the vice-president in his office at the university.
Sheikh Mohammed tweeted, “All the best to the Kingdom of Saudi Arabia and its leadership. The Saudi National Day every year is a dear occasion to all of us; an occasion to express our fraternal relations and love and move to a better and more prosperous future for two peoples combined by a limitless ambition.”
The health ministry also announced that 62,694 doses of the COVID-19 vaccine were provided during the past 24 hours, bringing the total doses that have been provided to date to 19,549,263.